Health Care & Life Sciences » Pharmaceuticals | Nanobac Pharmaceuticals Inc.

Nanobac Pharmaceuticals Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2003
2004
2005
2006
2007
Net Income before Extraordinaries
3,699.50
7,874.80
3,687.30
4,973.40
6,576.10
Depreciation, Depletion & Amortization
181.10
717.10
759.90
541.30
460.30
Other Funds
784.30
2,800.70
797.60
1,508.20
3,453.90
Funds from Operations
2,734.10
4,357.00
2,129.80
2,923.90
2,661.90
Changes in Working Capital
578.80
961.30
235.50
339.00
1,751.10
Net Operating Cash Flow
2,155.30
3,395.70
2,365.30
2,584.90
910.90
Capital Expenditures
18.20
36.80
40.60
12.80
1.50
Sale of Fixed Assets & Businesses
300.00
200.00
-
-
-
Net Investing Cash Flow
197.90
164.80
40.60
15.50
48.60
Issuance/Reduction of Debt, Net
1,474.80
2,038.50
2,161.80
2,688.90
910.90
Net Financing Cash Flow
2,022.80
3,216.00
2,326.10
2,688.90
910.90
Net Change in Cash
49.80
31.80
8.90
30.50
35.60
Free Cash Flow
2,173.50
3,432.50
2,405.90
2,597.60
912.40
Net Assets from Acquisitions
81.00
0.90
-
-
-
Other Sources
-
2.50
-
-
50.40
Change in Capital Stock
548.00
1,177.50
164.40
-
-
Exchange Rate Effect
15.60
16.90
70.90
58.00
84.10
Other Uses
2.90
-
-
2.70
0.30
Miscellaneous Funds
0.00
0.00
0.00
0.00
0.00

About Nanobac Pharmaceuticals

View Profile
Address
5025 West Lemon Street
Tampa Florida 33609
United States
Employees -
Website -
Updated 07/08/2019
Owns and operates community health centers .

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.